These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 10675760)
21. Rabies virus-specific human T cell clones provide help for an in vitro antibody response against neutralizing antibody-inducing determinants of the viral glycoprotein. Bunschoten H; Klapmuts RJ; Claassen IJ; Reyneveld SD; Osterhaus AD; Uytdehaag FG J Gen Virol; 1989 Jun; 70 ( Pt 6)():1513-21. PubMed ID: 2471814 [TBL] [Abstract][Full Text] [Related]
22. A rabies-specific human monoclonal antibody that protects mice against lethal rabies. Enssle K; Kurrle R; Köhler R; Müller H; Kanzy EJ; Hilfenhaus J; Seiler FR Hybridoma; 1991 Oct; 10(5):547-56. PubMed ID: 1804770 [TBL] [Abstract][Full Text] [Related]
23. First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity. Bakker AB; Python C; Kissling CJ; Pandya P; Marissen WE; Brink MF; Lagerwerf F; Worst S; van Corven E; Kostense S; Hartmann K; Weverling GJ; Uytdehaag F; Herzog C; Briggs DJ; Rupprecht CE; Grimaldi R; Goudsmit J Vaccine; 2008 Nov; 26(47):5922-7. PubMed ID: 18804136 [TBL] [Abstract][Full Text] [Related]
24. Development of human monoclonal antibodies to rabies. Dorfman N; Dietzschold B; Kajiyama W; Fu ZF; Koprowski H; Notkins AL Hybridoma; 1994 Oct; 13(5):397-402. PubMed ID: 7860096 [TBL] [Abstract][Full Text] [Related]
25. Isolation and characterization of novel human monoclonal antibodies possessing neutralizing ability against rabies virus. Matsumoto T; Yamada K; Noguchi K; Nakajima K; Takada K; Khawplod P; Nishizono A Microbiol Immunol; 2010 Nov; 54(11):673-83. PubMed ID: 21044141 [TBL] [Abstract][Full Text] [Related]
26. Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine. Dietzschold B; Gore M; Marchadier D; Niu HS; Bunschoten HM; Otvos L; Wunner WH; Ertl HC; Osterhaus AD; Koprowski H J Virol; 1990 Aug; 64(8):3804-9. PubMed ID: 1695255 [TBL] [Abstract][Full Text] [Related]
27. Evidence from the anti-idiotypic network that the acetylcholine receptor is a rabies virus receptor. Hanham CA; Zhao F; Tignor GH J Virol; 1993 Jan; 67(1):530-42. PubMed ID: 7677960 [TBL] [Abstract][Full Text] [Related]
28. Mechanisms of rabies virus neutralization by glycoprotein-specific monoclonal antibodies. Dietzschold B; Tollis M; Lafon M; Wunner WH; Koprowski H Virology; 1987 Nov; 161(1):29-36. PubMed ID: 3672933 [TBL] [Abstract][Full Text] [Related]
29. Alanine scanning of the rabies virus glycoprotein antigenic site III using recombinant rabies virus: implication for post-exposure treatment. Papaneri AB; Wirblich C; Marissen WE; Schnell MJ Vaccine; 2013 Dec; 31(49):5897-902. PubMed ID: 24120673 [TBL] [Abstract][Full Text] [Related]
30. [Preparation and Preliminary Application of a Virus Library for the Neutralizing Activity of a Monoclonal Antibody Against the Rabies Virus]. Yu P; Tao X; Wang L; Tang Q; Liu S; Zhu W Bing Du Xue Bao; 2016 Nov; 32(6):790-5. PubMed ID: 30004653 [TBL] [Abstract][Full Text] [Related]
31. Human rabies prevention--United States, 2008: recommendations of the Advisory Committee on Immunization Practices. Manning SE; Rupprecht CE; Fishbein D; Hanlon CA; Lumlertdacha B; Guerra M; Meltzer MI; Dhankhar P; Vaidya SA; Jenkins SR; Sun B; Hull HF; MMWR Recomm Rep; 2008 May; 57(RR-3):1-28. PubMed ID: 18496505 [TBL] [Abstract][Full Text] [Related]
32. [The development of neutralizing human antibodies against rabies virus]. Chen Z; Sun LN; Li C; Lv XJ; Tang Q; Liang MF; Li DX Bing Du Xue Bao; 2010 Jul; 26(4):271-5. PubMed ID: 20836379 [TBL] [Abstract][Full Text] [Related]
33. Binding properties of monoclonal antibodies to rabies virus. Cusi MG; Valensin PE; Tollis M; Bracci L; Petreni S; Soldani P Microbiologica; 1991 Jul; 14(3):205-11. PubMed ID: 1921740 [TBL] [Abstract][Full Text] [Related]
34. Preparation and identification of anti-rabies virus monoclonal antibodies. Wang WJ; Li X; Wang LH; Shan H; Cao L; Yu PC; Tang Q; Liang GD Virol Sin; 2012 Jun; 27(3):172-8. PubMed ID: 22684471 [TBL] [Abstract][Full Text] [Related]
35. Immunological relationships between rabies virus and rabies-related viruses studied with monoclonal antibodies to Mokola virus. Vincent J; Bussereau F; Sureau P Ann Inst Pasteur Virol; 1988; 139(2):157-73. PubMed ID: 3207504 [TBL] [Abstract][Full Text] [Related]
36. Experimental utility of rabies virus-neutralizing human monoclonal antibodies in post-exposure prophylaxis. Hanlon CA; DeMattos CA; DeMattos CC; Niezgoda M; Hooper DC; Koprowski H; Notkins A; Rupprecht CE Vaccine; 2001 Jul; 19(28-29):3834-42. PubMed ID: 11427255 [TBL] [Abstract][Full Text] [Related]
37. [Construction and detection the bioactivity of human anti-rabies virus scdsFv]. Yang R; Yang S; Wang C; Gao Y; Shan H; Xia X Wei Sheng Wu Xue Bao; 2011 Jan; 51(1):98-104. PubMed ID: 21465795 [TBL] [Abstract][Full Text] [Related]
38. Immune sera and antiglycoprotein monoclonal antibodies inhibit in vitro cell-to-cell spread of pathogenic rabies viruses. Lodmell DL; Ewalt LC J Virol; 1987 Oct; 61(10):3314-8. PubMed ID: 3625841 [TBL] [Abstract][Full Text] [Related]
39. Characterization of epitopes on the rabies virus glycoprotein by selection and analysis of escape mutants. Fallahi F; Wandeler AI; Nadin-Davis SA Virus Res; 2016 Jul; 220():161-71. PubMed ID: 27132040 [TBL] [Abstract][Full Text] [Related]